Carolyn J Douglas, MD

Dr. Fedoronko is an Assistant Clinical Professor of Psychiatry in the Consultation-Liaison and Behavioral Medicine division. He received an undergraduate degree in chemistry from Wayne State University before studying medicine at the University of Michigan Medical School. He completed residency in psychiatry at New York-Presbyterian Hospital/Weill Cornell Medical Center. He then came to Columbia to complete a fellowship in consultation-liaison psychiatry. He has remained on faculty since that time. He currently serves as liaison to the lung transplant, heart transplant, and heart failure programs at NewYork-Presbyterian Hospital. He additionally serves as a consultant to the general hospital. His interests include the management of mood and anxiety disorders in patients with severe medical illness and the influence of personality style on coping mechanisms and medical outcomes. He is active in teaching as he directs the consultation-liaison component of the third year medical student clerkship in psychiatry. Dr. Fedoronko is also active in clinical supervising and lecturing to psychiatry residents and fellows. Past honors include the William Webb Fellowship from the Academy of Psychosomatic Medicine, the outstanding graduate in consultation-liaison psychiatry from NewYork-Presbyterian Hospital/Weill Cornell Medical Center, the Raymond Waggoner Award from the University of Michigan Medical School, and election to Alpha Omega Alpha Honor Medical Society.

Dr. Attia received her A.B. from Princeton University in 1982 and her MD from Columbia University College of Physicians & Surgeons in 1986. Formerly the director of the inpatient eating disorders program at The New York State Psychiatric Institute, Dr. Attia has more recently focused on research involving the psychobiology and treatment of anorexia nervosa. Since 1999, she has received uninterrupted funding for her research from the National Institute of Mental Health (NIMH).Dr. Attia has received a Young Investigator Award from The National Alliance for Research in Schizophrenia and Depression (NARSAD), a Pfizer/Society for Womens Health Research Faculty Development Award in Womens Health, and a Career Development Award from NIMH. Dr. Attia is a member of the eating disorders work-group for DSM-5. She is also a member of The Eating Disorders Research Society and has been elected Fellow of the Academy for Eating Disorders.

Stanley Chang, M.D., is the former Edward S. Harkness Professor and Chairman of the Department of Ophthalmology at Columbia University Medical Center. He is also the K.K. Tse and Ku Teh Ying Professor of Ophthalmology. He is a specialist in vitreoretinal disorders and surgery and pioneered many of the surgical techniques currently used in this field. Dr. Chang received a B.S. degree from the Massachusetts Institute of Technology, a M.S. from the University of Pennsylvania, and completed his M.D. degree at the Vagelos College of Physicians and Surgeons of Columbia University. After a vitreoretinal surgery fellowship at the Bascom Palmer Eye Institute, Dr. Chang joined the faculty of Department of Ophthalmology at Cornell University Medical School, where he became Professor of Ophthalmology. Appointed the Edward S. Harkness Professor and Chairman of the Department of Ophthalmology in 1995, he served as director of the Edward S. Harkness Eye Institute until 2012. Dr. Chang has developed and pioneered several revolutionary surgical approaches to treat complicated forms of retinal detachment, improving outcomes for patients worldwide. He was the first to use perfluoropropane (C3F8) gas in the management of retinal detachments caused by scar tissue growth (PVR) on the retina. This gas is the most frequently used gas in complex vitreoretinal surgeries. He developed perfluorocarbon liquids, a 'heavy liquid' used in flattening retinal detachment, and changed the management of giant retinal tears and retinal detachments resulting from trauma globally. In collaboration with Avi Grinblat, he developed a panoramic viewing system and led in the worldwide adaptation by retina surgeons to this technique. Through research and innovation, he continues to improve the clinical outcomes for patients. He is the recipient of several honors including the Herman Wacker Prize from the Club Jules Gonin, Helmerich Prize from the American Society of Retina Specialists, the Lifetime Achievement Award and the Secretariat Award from the American Academy of Ophthalmology, the Edward Jackson Lecture, the Charles Schepens Lecture, the Donald M Gass Lecture, and the Jules Gonin Medal from the International Council of Ophthalmology. Consistently named as one of America's best doctors, Dr. Chang was also recognized as one of three physicians selected as National Physician of the Year by the Castle Connolly Guides in 2008. The Department of Ophthalmology is grateful to Dr. Chang for his exemplary and inspirational leadership during his time as Chair and Director of Ophthalmology. During his tenure, the department attracted a top-notch team of researchers and clinicians, developed new faculty practices in New York and New Jersey, more than doubled the number of surgical cases in the Eye Institute, and dramatically increased research funding. Dr. Chang remains an active member of the faculty and continues his patient care, research and teaching commitments.